Growth Metrics

Microbot Medical (MBOT) Current Deferred Revenue (2016)

Historic Current Deferred Revenue for Microbot Medical (MBOT) over the last 7 years, with Q3 2016 value amounting to $16826.0.

  • Microbot Medical's Current Deferred Revenue fell 8635.73% to $16826.0 in Q3 2016 from the same period last year, while for Sep 2016 it was $16826.0, marking a year-over-year decrease of 8635.73%. This contributed to the annual value of $132338.0 for FY2015, which is N/A changed from last year.
  • According to the latest figures from Q3 2016, Microbot Medical's Current Deferred Revenue is $16826.0, which was down 8635.73% from $16826.0 recorded in Q2 2016.
  • Over the past 5 years, Microbot Medical's Current Deferred Revenue peaked at $141344.0 during Q1 2016, and registered a low of $16826.0 during Q2 2016.
  • In the last 5 years, Microbot Medical's Current Deferred Revenue had a median value of $67245.0 in 2013 and averaged $69994.7.
  • Its Current Deferred Revenue has fluctuated over the past 5 years, first surged by 11424.96% in 2014, then crashed by 8635.73% in 2016.
  • Quarter analysis of 5 years shows Microbot Medical's Current Deferred Revenue stood at $74426.0 in 2012, then dropped by 9.65% to $67245.0 in 2013, then increased by 27.78% to $85925.0 in 2014, then surged by 54.02% to $132338.0 in 2015, then tumbled by 87.29% to $16826.0 in 2016.
  • Its last three reported values are $16826.0 in Q3 2016, $16826.0 for Q2 2016, and $141344.0 during Q1 2016.